MacEwen Clare, Sutherland Sheera, Daly Jonathan, Pugh Christopher, Tarassenko Lionel
Oxford Kidney Unit, Oxford University Hospitals National Health Service Trust, Oxford, United Kingdom;
Institute of Biomedical Engineering, Department of Engineering Science, and.
J Am Soc Nephrol. 2017 Aug;28(8):2511-2520. doi: 10.1681/ASN.2016060704. Epub 2017 Mar 7.
The relationship between BP and downstream ischemia during hemodialysis has not been characterized. We studied the dynamic relationship between BP, real-time symptoms, and cerebral oxygenation during hemodialysis, using continuous BP and cerebral oxygenation measurements prospectively gathered from 635 real-world hemodialysis sessions in 58 prevalent patients. We examined the relationship between BP and cerebral ischemia (relative drop in cerebral saturation >15%) and explored the lower limit of cerebral autoregulation at patient and population levels. Furthermore, we estimated intradialytic exposure to cerebral ischemia and hypotension for each patient, and entered these values into multivariate models predicting change in cognitive function. In all, 23.5% of hemodialysis sessions featured cerebral ischemia; 31.9% of these events were symptomatic. Episodes of hypotension were common, with mean arterial pressure falling by a median of 22 mmHg (interquartile range, 14.3-31.9 mmHg) and dropping below 60 mmHg in 24% of sessions. Every 10 mmHg drop from baseline in mean arterial pressure associated with a 3% increase in ischemic events (<0.001), and the incidence of ischemic events rose rapidly below an absolute mean arterial pressure of 60 mmHg. Overall, however, BP poorly predicted downstream ischemia. The lower limit of cerebral autoregulation varied substantially (mean 74.1 mmHg, SD 17.6 mmHg). Intradialytic cerebral ischemia, but not hypotension, correlated with decreased executive cognitive function at 12 months (=0.03). This pilot study demonstrates that intradialytic cerebral ischemia occurs frequently, is not easily predicted from BP, and may be clinically significant.
血液透析期间血压(BP)与下游缺血之间的关系尚未明确。我们利用从58例门诊患者的635次实际血液透析治疗中前瞻性收集的连续血压和脑氧合测量数据,研究了血液透析期间血压、实时症状和脑氧合之间的动态关系。我们检查了血压与脑缺血(脑饱和度相对下降>15%)之间的关系,并在患者和总体水平上探索了脑自动调节的下限。此外,我们估计了每位患者透析期间脑缺血和低血压的暴露情况,并将这些值纳入预测认知功能变化的多变量模型中。总体而言,23.5%的血液透析治疗出现脑缺血;其中31.9%的事件有症状。低血压发作很常见,平均动脉压中位数下降22 mmHg(四分位间距,14.3 - 31.9 mmHg),24%的治疗中平均动脉压降至60 mmHg以下。平均动脉压较基线每下降10 mmHg,缺血事件增加3%(<0.001),且在绝对平均动脉压低于60 mmHg时缺血事件发生率迅速上升。然而,总体而言,血压对下游缺血的预测能力较差。脑自动调节的下限差异很大(平均74.1 mmHg,标准差17.6 mmHg)。透析期间的脑缺血而非低血压与12个月时执行认知功能下降相关(=0.03)。这项初步研究表明,透析期间脑缺血频繁发生,难以通过血压预测,且可能具有临床意义。